Back to Trades
Accardi Mario Alberto
Chief Executive OfficerDirectorCIK 0002074392
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 10
- Buy transactions
- 0
- Sell transactions
- 8
- Companies
- 1
- Active
- 2025–2026
Accardi Mario Alberto, Chief Executive Officer, Director, accounts for 10 disclosed filings worth $19.7M, all concentrated in Centessa Pharmaceuticals plc (CNTA), active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $1.2M in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
10 loaded
| Jun 24 | CNTA Centessa Pharmaceuticals plc | Accardi Mario Alberto | Chief Executive Officer, Director | Disposed | $11.2M |
| May 18 | CNTA Centessa Pharmaceuticals plc | Accardi Mario Alberto | Chief Executive Officer, Director | Tax withheld | $23.8K |
| Feb 3 | CNTA Centessa Pharmaceuticals plc | Accardi Mario Alberto | Chief Executive Officer, Director | Grant | $6.9M |
| Dec 9 | CNTA Centessa Pharmaceuticals plc | Accardi Mario Alberto | President, Orexin Program | Sell | $288.3K |
| Dec 8 | CNTA Centessa Pharmaceuticals plc | Accardi Mario Alberto | President, Orexin Program | Sell | $300.0K |
| Oct 27 | CNTA Centessa Pharmaceuticals plc | Accardi Mario Alberto | President, Orexin Program | Sell | $200.0K |
| Sep 16 | CNTA Centessa Pharmaceuticals plc | Accardi Mario Alberto | President, Orexin Program | Sell | $174.8K |
| Sep 11 | CNTA Centessa Pharmaceuticals plc | Accardi Mario Alberto | President, Orexin Program | Sell | $140.0K |
| Aug 1 | CNTA Centessa Pharmaceuticals plc | Accardi Mario Alberto | President, Orexin Program | Tax withheld | $10.3K |
| Jul 30 | CNTA Centessa Pharmaceuticals plc | Accardi Mario Alberto | President, Orexin Program | Sell | $126.8K |
10 filings